Seoulin Bioscience Co.,Ltd. Statistics

Total Valuation

Seoulin Bioscience Co.,Ltd. has a market cap or net worth of KRW 61.57 billion. The enterprise value is 39.32 billion.

Market Cap	61.57B
Enterprise Value	39.32B

Important Dates

The next estimated earnings date is Tuesday, March 18, 2025.

Earnings Date	Mar 18, 2025
Ex-Dividend Date	Dec 27, 2024

Share Statistics

Seoulin Bioscience Co.,Ltd. has 8.55 million shares outstanding. The number of shares has decreased by -5.80% in one year.

Current Share Class	n/a
Shares Outstanding	8.55M
Shares Change (YoY)	-5.80%
Shares Change (QoQ)	+0.52%
Owned by Insiders (%)	29.90%
Owned by Institutions (%)	0.37%
Float	6.00M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.75
PB Ratio	0.72
P/TBV Ratio	0.74
P/FCF Ratio	53.78
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 18.57, with an EV/FCF ratio of 34.34.

EV / Earnings	-59.43
EV / Sales	0.48
EV / EBITDA	18.57
EV / EBIT	47.83
EV / FCF	34.34

Financial Position

The company has a current ratio of 4.98, with a Debt / Equity ratio of 0.02.

Current Ratio	4.98
Quick Ratio	2.75
Debt / Equity	0.02
Debt / EBITDA	0.87
Debt / FCF	1.54
Interest Coverage	0.90

Financial Efficiency

Return on equity (ROE) is -3.56% and return on invested capital (ROIC) is 0.47%.

Return on Equity (ROE)	-3.56%
Return on Assets (ROA)	0.39%
Return on Capital (ROIC)	0.47%
Revenue Per Employee	789.36M
Profits Per Employee	-6.36M
Employee Count	104
Asset Turnover	0.70
Inventory Turnover	2.58

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -17.73% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-17.73%
50-Day Moving Average	7,185.00
200-Day Moving Average	8,283.50
Relative Strength Index (RSI)	47.19
Average Volume (20 Days)	1,046,360

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Seoulin Bioscience Co.,Ltd. had revenue of KRW 82.09 billion and -661.53 million in losses. Loss per share was -77.39.

Revenue	82.09B
Gross Profit	17.95B
Operating Income	737.13M
Pretax Income	-2.61B
Net Income	-661.53M
EBITDA	2.03B
EBIT	737.13M
Loss Per Share	-77.39

Full Income Statement

Balance Sheet

The company has 24.81 billion in cash and 1.76 billion in debt, giving a net cash position of 23.05 billion or 2,695.13 per share.

Cash & Cash Equivalents	24.81B
Total Debt	1.76B
Net Cash	23.05B
Net Cash Per Share	2,695.13
Equity (Book Value)	84.88B
Book Value Per Share	9,958.87
Working Capital	45.68B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.45 billion and capital expenditures -304.63 million, giving a free cash flow of 1.14 billion.

Operating Cash Flow	1.45B
Capital Expenditures	-304.63M
Free Cash Flow	1.14B
FCF Per Share	133.88

Full Cash Flow Statement

Margins

Gross margin is 21.87%, with operating and profit margins of 0.90% and -0.81%.

Gross Margin	21.87%
Operating Margin	0.90%
Pretax Margin	-3.18%
Profit Margin	-0.81%
EBITDA Margin	2.48%
EBIT Margin	0.90%
FCF Margin	1.39%

Dividends & Yields

This stock pays an annual dividend of 97.66, which amounts to a dividend yield of 1.36%.

Dividend Per Share	97.66
Dividend Yield	1.36%
Dividend Growth (YoY)	-21.24%
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	5.80%
Shareholder Yield	7.15%
Earnings Yield	-1.07%
FCF Yield	1.86%

Dividend Details

Stock Splits

The last stock split was on December 27, 2023. It was a forward split with a ratio of 1.0239188.

Last Split Date	Dec 27, 2023
Split Type	Forward
Split Ratio	1.0239188

Scores

Seoulin Bioscience Co.,Ltd. has an Altman Z-Score of 5.9.

Altman Z-Score	5.9
Piotroski F-Score	n/a